Exploring Potential Treatment Options for COVID-19

Annie Luetkemeyer, MD, professor of infectious diseases at UCSF, is an expert on the treatment of viral infections. On March 24, 2020, Robert Wachter, MD, chair of the Department of Medicine at UCSF, interviewed her on the evidence behind potential treatments for COVID-19 (including chloroquine/hydroxychloroquine, remdesivir and others), as well as how to assess new and existing drugs in a pandemic.

Related Presenters

Robert M. Wachter, MD.

Robert M. Wachter, MD

Chair of the Department of Medicine

Dr. Robert M. Wachter is chair of the UCSF Department of Medicine, which leads the nation in grants from the National Institutes of Health and is consistently ranked as one of the nation’s best. His primary interests are health care quality, ...

View Profile

Annie Luetkemeyer, MD.

Annie Luetkemeyer, MD

Infectious Diseases

Education and Training University of California, San Francisco 2006 Advanced Training in Clinical Research University of California, San Francisco, SFVAMC 2003 Internal Medicine  University of California, San Francisco 2002 Internal ...

View Profile

Related Videos